Stewart Lancaster works in the field of Hematology. He researched medicine at Penn State College of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Stewart L. Lancaster is a published doctor. He has 1 publication published. The most current publication "Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer." He accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1154392215 | |
NPPES Provider LastName | LANCASTER | |
NPPES Provider FirstName | STEWART | |
NPPES Provider ZIPCode | 150091919 | |
NPPES Provider State | PA | |
Specialty Description | Medical Oncology | |
Total Claim Count | 1115.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 143.0 | |
Percent Opioid Claims | 12.83 |
National Provider Identifier [NPI] | 1154392215 |
Last Name Of The Provider | LANCASTER |
First Name Of The Provider | STEWART |
View All |
![]() |
Dr. Grace R. Tarabay, MD
![]() ![]() |
![]() |
Dr. Carolyn C. Chen, MD
![]() |
![]() |
Dr. Thomas W. McCreary III, MD
![]() |